Projects
Reading
People
Chat
SU\G
(𝔸)
/K·U
Projects
Reading
People
Chat
Sign Up
Sign In
Light
Dark
System
Catey Bunce
Follow
Share
Generating author description...
All published works
Action
Title
Year
Authors
+
Common Statistical Issues in Ophthalmic Research
2022
Catey Bunce
Gabriela Czanner
+
Protocol amendments summary
2021
Daniel Fp Larkin
Kashfia Chowdhury
Caroline J Doré
Catey Bunce
Jennifer Burr
Emilia Caverly
Lisa French
Dimitra Kopsini
Anne Klepacz
Mathew K. Raynor
+
Survival Analysis vs Longitudinal Modeling With Multiple Imputation—a False Dichotomy—Reply
2021
Catey Bunce
Dun Jack Fu
Irene Stratton
+
PDF
Chat
The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
2020
Munyaradzi Dimairo
Philip Pallmann
James Wason
Susan Todd
Thomas Jaki
Steven A. Julious
Adrian Mander
Christopher J. Weir
Franz Koenig
Marc K. Walton
+
PDF
Chat
Selective recruitment designs for improving observational studies using electronic health records
2020
James E. Barrett
Sera Aylin Cakiroglu
Catey Bunce
Anoop D Shah
Spiros Denaxas
+
Selective recruitment designs for improving observational studies using electronic health records
2019
James E. Barrett
Sera Aylin Cakiroglu
Catey Bunce
Anoop D Shah
Spiros Denaxas
+
Statistical analysis and design in ophthalmology: Toward optimizing your data
2019
Gabriela Czanner
Catey Bunce
+
Selective recruitment designs for improving observational studies using electronic health records
2019
James E. Barrett
Sera Aylin Cakiroglu
Catey Bunce
Anoop Shah
Spiros Denaxas
+
PDF
Chat
Ophthalmic statistics note 8: missing data—exploring the unknown
2015
Catey Bunce
Ana Quartilho
Nick Freemantle
Caroline J Doré
+
PDF
Chat
Certification figures and their accuracy
2015
Ana Quartilho
Antra Zekite
W Xing
Mohamed Loutfi
Catey Bunce
Richard Wormald
+
RIPOSTE: a framework for improving the design and analysis of laboratory-based research
2015
Nicholas G. D. Masca
E. Hensor
Victoria Cornelius
Francesca M. Buffa
Helen M. Marriott
James Eales
Michael Messenger
Amy E. Anderson
Chris Boot
Catey Bunce
+
RIPOSTE: a framework for improving the design and analysis of laboratory-based research Lack of reproducibility is an ongoing problem in some areas of the biomedical sciences.
2015
Nicholas G. D. Masca
E. Hensor
Victoria Cornelius
Francesca M. Buffa
Helen M. Marriott
James Eales
Michael Messenger
Amy E. Anderson
Chris Boot
Catey Bunce
+
PDF
Chat
Ophthalmic statistics note 5: diagnostic tests—sensitivity and specificity
2014
Luke J. Saunders
Haogang Zhu
Catey Bunce
Caroline J Doré
Nick Freemantle
David P. Crabb
+
PDF
Chat
Ophthalmic statistics note: the perils of dichotomising continuous variables
2014
Phillippa Cumberland
Gabriela Czanner
Catey Bunce
Caroline J Doré
Nick Freemantle
Marta García‐Fiñana
+
Attention should be given to multiplicity issues in systematic reviews
2008
Ralf Bender
Catey Bunce
Mike Clarke
Simon Gates
Stefan Lange
Nathan L. Pace
Kristian Thorlund
Common Coauthors
Coauthor
Papers Together
Caroline J Doré
4
Sera Aylin Cakiroglu
3
Spiros Denaxas
3
Gabriela Czanner
3
Nick Freemantle
3
James E. Barrett
3
Janet L. Peacock
2
James Eales
2
E. Hensor
2
Karl J. Staples
2
Hiba Junaid
2
Nicholas G. D. Masca
2
Paul T. Seed
2
Carmen Martín-Ruiz
2
Jamie Toombs
2
M. Dawn Teare
2
Shaun Kingston
2
Ana Quartilho
2
Helen M. Marriott
2
Robert Goldin
2
Victoria Cornelius
2
Bethany Shinkins
2
Anoop D Shah
2
Francesca M. Buffa
2
Chris Boot
2
Jessica Harris
2
Amy E. Anderson
2
Michael Messenger
2
Christopher P. Nelson
2
Adam KA Wright
2
Rod F Hinchliffe
2
Marc K. Walton
1
Elizabeth Coates
1
Lisa French
1
Marta García‐Fiñana
1
Dun Jack Fu
1
W Xing
1
Adrian Mander
1
Susan Todd
1
Olivier Collignon
1
Yannis Jemiai
1
Jon Nicholl
1
I M Stratton
1
Douglas G. Altman
1
Yukio Ando
1
Anne Klepacz
1
Sally Hopewell
1
Philip Pallmann
1
Richard Wormald
1
Deborah Ashby
1
Commonly Cited References
Action
Title
Year
Authors
# of times referenced
+
Strategy for intention to treat analysis in randomised trials with missing outcome data
2011
Ian R. White
Nicholas J. Horton
James R. Carpenter
r. i. m. a. s. statistics
Stuart J. Pocock
2
+
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001
D G Altman
2
+
PDF
Chat
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
2001
David Moher
Kenneth F. Schulz
Douglas G. Altman
2
+
PDF
Chat
Deriving chemosensitivity from cell lines: Forensic bioinformatics and reproducible research in high-throughput biology
2009
Keith Baggerly
Kevin R. Coombes
2
+
PDF
Chat
Analysing randomised controlled trials with missing data: Choice of approach affects conclusions
2012
Shona Fielding
Peter Fayers
Craig Ramsay
2
+
PDF
Chat
Multiple Imputation
2015
Peng Li
Elizabeth A. Stuart
David B. Allison
2
+
PDF
Chat
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
2012
Douglas G. Altman
Lisa M. McShane
Willi Sauerbrei
Sheila E. Taube
2
+
Assessing Individual Agreement
2007
Huiman X. Barnhart
Andrzej S. Kosinski
Michael Haber
2
+
Practical and statistical issues in missing data for longitudinal patient-reported outcomes
2013
Melanie L. Bell
Diane L. Fairclough
2
+
PDF
Chat
Increasing value and reducing waste in research design, conduct, and analysis
2014
John P. A. Ioannidis
Sander Greenland
Mark A. Hlatky
Muin J. Khoury
Malcolm Macleod
David Moher
Kenneth F. Schulz
Robert Tibshirani
2
+
PDF
Chat
Learning from our GWAS mistakes: from experimental design to scientific method
2012
Christophe G Lambert
Lynsey Black
2
+
PDF
Chat
Missing data
2007
Douglas G. Altman
Martin Bland
2
+
Designing Multi-arm Multi-stage Clinical Studies
2014
Thomas Jaki
1
+
Effect Measures for Meta‒Analysis of Trials with Binary Outcomes
2001
Jonathan J Deeks
Douglas G. Altman
1
+
The Design of Experiments
1935
Ronald Aylmer Fisher
1
+
PDF
Chat
Bivariate random-effects meta-analysis and the estimation of between-study correlation
2007
Richard D. Riley
Keith R. Abrams
Alex J. Sutton
Paul C. Lambert
John R. Thompson
1
+
Going Beyond the Grand Mean: Subgroup Analysis in Meta‐Analysis of Randomised Trials
2001
George Davey Smith
Matthias Egger
1
+
PDF
Chat
No solution yet for combining two independent studies in the presence of heterogeneity
2015
Andrea Gonnermann
Theodor Framke
Anika Großhennig
Armin Koch
1
+
Confidentiality and Trial Integrity Issues for Adaptive Designs
2006
Paul Gallo
1
+
Adaptive Dunnett tests for treatment selection
2007
Franz Koenig
Werner Brannath
Frank Bretz
Martin Posch
1
+
PDF
Chat
CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration
2008
Sally Hopewell
Mike Clarke
David Moher
Elizabeth Wager
Philippa Middleton
Douglas G. Altman
Kenneth F. Schulz
1
+
Sample size adjustment based on promising interim results and its application in confirmatory clinical trials
2015
YH Joshua Chen
Caiyan Li
KK Gordon Lan
1
+
Stochastically curtailed tests in long–term clinical trials
1982
K. K. Gordon Lan
Richard Simon
Max Halperin
1
+
Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis
2007
Jørn Wetterslev
Kristian Thorlund
Jesper Brok
Christian Gluud
1
+
Testing multiple statistical hypotheses resulted in spurious associations: a study of astrological signs and health
2006
Peter C. Austin
Muhammad Mamdani
David N. Juurlink
Janet E. Hux
1
+
One‐ and two‐stage design proposals for a phase II trial comparing three active treatments with control using an ordered categorical endpoint
2008
John Whitehead
Thomas Jaki
1
+
Parameter estimation following group sequential hypothesis testing
1990
Scott S. Emerson
Thomas R. Fleming
1
+
Similarities and Differences of Bayesian Designs and Adaptive Designs for Medical Devices: A Regulatory View
2013
Gregory Campbell
1
+
Stopping a trial early – and then what?
2012
Janet Wittes
1
+
Statistical Principles for Clinical Trials
1998
Robert R. Kay
1
+
Group Sequential Methods with Applications to Clinical Trials
1999
Christopher Jennison
Bruce W. Turnbull
1
+
Sample Size Tables for Clinical Studies
2008
David Machin
Michael J. Campbell
Say Beng Tan
Sze Huey Tan
1
+
PDF
Chat
Adaptive sample size modification in clinical trials: start small then ask for more?
2015
Christopher Jennison
Bruce W. Turnbull
1
+
Benefit–risk assessment: the use of clinical utility index
2010
Danièle Ouellet
1
+
The advantages and disadvantages of adaptive designs for clinical trials
2004
Péter Bauer
Werner Brannath
1
+
PDF
Chat
Optimal multistage designs for randomised clinical trials with continuous outcomes
2011
James Wason
Adrian Mander
Simon G. Thompson
1
+
Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
2004
John P. A. Ioannidis
1
+
Designed Extension of Studies Based on Conditional Power
1995
Michael A. Proschan
Sally Hunsberger
1
+
PDF
Chat
Flexible sequential designs for multi‐arm clinical trials
2014
Dominic Magirr
Nigel Stallard
Thomas Jaki
1
+
Monitoring clinical trials: Conditional or predictive power?
1986
David J. Spiegelhalter
Laurence S. Freedman
Patrick R. Blackburn
1
+
PDF
Chat
Simulation study for evaluating the performance of response-adaptive randomization
2014
Yining Du
Xuan Wang
J. Jack Lee
1
+
Multiple Testing in Clinical Trials
2005
Alexei Dmitrienko
Jason C. Hsu
1
+
Sampling of Populations: Methods and Applications
1992
Eric R. Ziegel
Patrick Lévy
S. Lemeshaw
1
+
Cumulating evidence from randomized trials: Utilizing sequential monitoring boundaries for cumulative meta-analysis
1997
Janice Pogue
Salim Yusuf
1
+
Confirmatory Clinical Trials with an Adaptive Design
2006
Armin Koch
1
+
Blinded Sample Size Reestimation in Multiarmed Clinical Trials
2000
Meinhard Kieser
Tim Friede
1
+
Coordinating Data Monitoring Committees and Adaptive Clinical Trial Designs
2008
Jay Herson
1
+
Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial
1975
Stuart J. Pocock
Richard Simon
1
+
PDF
Chat
Three steps to writing adaptive study protocols in the early phase clinical development of new medicines
2014
Ulrike Lorch
Martin O’Kane
Jӧrg Täubel
1
+
Combining different phases in the development of medical treatments within a single trial
1999
Péter Bauer
Meinhard Kieser
1